brca1 gene mutation
Showing 1 - 22 of 22
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +5 more
- Durvalumab
- +3 more
-
Buffalo, New York
- +1 more
Jan 20, 2023
Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)
Active, not recruiting
- Breast Cancer
- +3 more
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker
Recruiting
- BRCA1 Gene Mutation
- +19 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
New Brunswick, New Jersey
- +1 more
Nov 16, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation Trial in Netherlands (Risk-reducing salpingectomy with delayed
Recruiting
- BRCA1 Gene Mutation
- +5 more
- Risk-reducing salpingectomy with delayed oophorectomy
- Risk-reducing salpingo-oophorectomy
-
Tilburg, Brabant, Netherlands
- +13 more
Nov 1, 2022
ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,
Recruiting
- ATM Gene Mutation
- +16 more
- Niraparib
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 27, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic
Recruiting
- BARD1 Gene Mutation
- +14 more
- Educational Intervention
- +3 more
-
Houston, Texas
- +1 more
Jun 14, 2022
BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic
Recruiting
- BRCA-Mutated Ovarian Carcinoma
- +30 more
- Chemotherapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,
Active, not recruiting
- BRCA1 Gene Mutation
- +2 more
- Salpingectomy with delayed oophorectomy
- Risk-reducing salpingo-oophorectomy
-
Maastricht, Limburg, Netherlands
- +12 more
May 17, 2022
Prospective Research of Outcomes After Salpingo-oophorectomy
Active, not recruiting
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 21, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)
Recruiting
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- Informational Intervention
- Survey Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 2, 2022
Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,
Active, not recruiting
- Advanced Malignant Neoplasm
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2022
Tumors, Breast, Carcinoma of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Worldwide (niraparib,
Completed
- Neoplasms, Breast
- +5 more
- niraparib
- Physician's choice
-
Tucson, Arizona
- +103 more
Nov 2, 2021
ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation Trial in Canada, United States (Laboratory Biomarker Analysis,
Completed
- ATM Gene Mutation
- +20 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +1156 more
Jun 22, 2021
BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Petah-Tikva (DIM-Avail 100mg)
Completed
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- DIM-Avail 100mg
-
Petah-Tikva, IsraelRabin Medical Center, Beilinson Hospital
Nov 9, 2020
Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (curcumin, Biomarker analysis,
Completed
- Atypical Ductal Breast Hyperplasia
- +4 more
- curcumin
- +3 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Aug 29, 2019
Pancreatic Tumors, Peutz-Jegher's Syndrome, BRCA1 Gene Mutation Trial in Little Rock (Pancreatic Cancer Screening Pathway 1,
Withdrawn
- Pancreatic Neoplasms
- +7 more
- Pancreatic Cancer Screening Pathway 1
- Pancreatic Cancer Screening Pathway 2
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jul 25, 2019
BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Petah Tikva (Endothelial function assessment, Cardiovascular biomarkers,
Unknown status
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- Endothelial function assessment
- +2 more
-
Petah Tikva, IsraelRabin Medical Center, Beilinson Hospital
Jul 13, 2017
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Breast Cancer Trial in London, Toronto (Follow-up Telephone Genetic Counselling)
Unknown status
- BRCA1 Gene Mutation
- +3 more
- Follow-up Telephone Genetic Counselling
-
London, Ontario, Canada
- +2 more
Jun 7, 2016
BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Jerusalem
Unknown status
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
-
Jerusalem, IsraelHadassah medical center
Jul 24, 2013